Literature DB >> 21883369

Histiocytic sarcoma transdifferentiated from follicular lymphoma presenting as a cutaneous tumor.

Weifen Zeng1, Jeanne Meck, Bruce D Cheson, Metin Ozdemirli.   

Abstract

Histiocytic sarcoma represents a rare and poorly understood tumor of histiocytic/dendritic cell lineage that can rarely present in the skin. Previously reported cases of histiocytic sarcoma after follicular lymphoma suggested that follicular lymphoma can transdifferentiate into histiocytic sarcoma. We describe another case involving a 40-year old male who developed histiocytic sarcoma in his right thigh 4 years after the diagnosis of grade 1 follicular lymphoma in the left neck. The two neoplasms were morphologically and immunophenotypically different but had identical immunoglobulin heavy chain gene and bcl-2 gene rearrangements, as demonstrated by polymerase chain gene reaction analysis, and the presence of t(14;18)(q32;q21) translocation was confirmed via fluorescence in situ hybridization (FISH) analysis. Because of spindle cell morphology and focal S-100 positivity, malignant peripheral nerve sheath tumor and melanoma diagnoses were made initially and extensive workup was required to discover the correct diagnosis. Lineage transdifferentiation can occur in mature lymphoid neoplasms and awareness of this phenomenon and appropriate workup is crucial for correct diagnosis, as different treatment protocols and prognosis may vary.
Copyright © 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21883369     DOI: 10.1111/j.1600-0560.2011.01769.x

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.587


  6 in total

1.  Follicular lymphoma transformation into histiocytic sarcoma: indications for a common neoplastic progenitor.

Authors:  P Brunner; A Rufle; S Dirnhofer; A Lohri; N Willi; G Cathomas; A Tzankov; D Juskevicius
Journal:  Leukemia       Date:  2014-05-21       Impact factor: 11.528

Review 2.  Subsequent development of histiocytic sarcoma and follicular lymphoma: cytogenetics and next-generation sequencing analyses provide evidence for transdifferentiation of early common lymphoid precursor-a case report and review of literature.

Authors:  Sarah Péricart; Charlotte Waysse; Aurore Siegfried; Stephanie Struski; Eric Delabesse; Camille Laurent; Solène Evrard
Journal:  Virchows Arch       Date:  2019-12-05       Impact factor: 4.064

3.  Chromosome Condensation 1-Like (Chc1L) Is a Novel Tumor Suppressor Involved in Development of Histiocyte-Rich Neoplasms.

Authors:  David R Spillane; Ding Yan Wang; Susan Newbigging; Youdong Wang; Chang-Xin Shi; Hae-Ra Cho; Hiroki Shimizu; Anthony Gramolini; Mingyao Liu; Xiao-Yan Wen
Journal:  PLoS One       Date:  2015-08-20       Impact factor: 3.240

4.  Clinicopathologic characteristics and outcomes of histiocytic and dendritic cell neoplasms: the moffitt cancer center experience over the last twenty five years.

Authors:  Samir Dalia; Michael Jaglal; Paul Chervenick; Hernani Cualing; Lubomir Sokol
Journal:  Cancers (Basel)       Date:  2014-11-14       Impact factor: 6.639

5.  Histiocytic cell neoplasms involving the bone marrow: summary of the workshop cases submitted to the 18th Meeting of the European Association for Haematopathology (EAHP) organized by the European Bone Marrow Working Group, Basel 2016.

Authors:  Alexandar Tzankov; Markus Kremer; Roos Leguit; Attilio Orazi; Jon van der Walt; Umberto Gianelli; Konnie M Hebeda
Journal:  Ann Hematol       Date:  2018-08-06       Impact factor: 3.673

6.  Spectrum of histiocytic neoplasms associated with diverse haematological malignancies bearing the same oncogenic mutation.

Authors:  Paul G Kemps; Konnie M Hebeda; Steven T Pals; Robert M Verdijk; King H Lam; Annette H Bruggink; Heleen S de Lil; Bart Ruiterkamp; Koen de Heer; Jan Am van Laar; Peter Jm Valk; Pim Mutsaers; Mark-David Levin; Pancras Cw Hogendoorn; Astrid Gs van Halteren
Journal:  J Pathol Clin Res       Date:  2020-08-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.